Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessandro Rizzo

Showing results (181-190 of 381) with videos related to

Pageof 39
Sort By:
Expert Opinion on Drug Safety|April 13, 2023
An update on safety evaluation of immune-based combinations in patients with advanced renal cell carcinomaMatteo Rosellini, Elisa Tassinari, Andrea Marchetti, et al.
Nature Computational Science|January 13, 2024
Vector-based pedestrian navigation in citiesChristian Bongiorno, Yulun Zhou, Marta Kryven, et al.
Expert Opinion on Investigational Drugs|June 25, 2021
Lenvatinib plus pembrolizumab: the next frontier for the treatment of hepatocellular carcinoma?Alessandro Rizzo, Vincenzo Dadduzio, Angela Dalia Ricci, et al.
Anti-Cancer Drugs|August 13, 2021
Platinum-based adjuvant chemotherapy for upper tract urothelial carcinoma: a change of paradigm? A meta-analysis of aggregate dataAngela Dalia Ricci, Alessandro Rizzo, Veronica Mollica, et al.
Applied Network Science|October 3, 2022
Activity-driven network modeling and control of the spread of two concurrent epidemic strainsDaniel Alberto Burbano Lombana, Lorenzo Zino, Sachit Butail, et al.
Frontiers in Molecular Biosciences|December 19, 2022
The association between albumin levels and survival in patients treated with immune checkpoint inhibitors: A systematic review and meta-analysisDeniz Can Guven, Taha Koray Sahin, Enes Erul, et al.
Critical Reviews in Oncology/Hematology|October 14, 2020
Beyond EGFR, ALK and ROS1: Current evidence and future perspectives on newly targetable oncogenic drivers in lung adenocarcinomaGiuseppe Lamberti, Elisa Andrini, Monia Sisi, et al.
Translational Cancer Research|February 4, 2022
Adjuvant treatment in biliary tract cancerAndrea Palloni, Giorgio Frega, Stefania De Lorenzo, et al.
Journal of Personalized Medicine|August 26, 2022
Molecular Profile and Prognostic Value of <i>BAP1</i> Mutations in Intrahepatic Cholangiocarcinoma: A Genomic Database AnalysisAlessandro Rizzo, Riccardo Carloni, Angela Dalia Ricci, et al.
Frontiers in Pharmacology|November 16, 2020
Challenges in Repurposing Drugs in COVID-19 Pandemic. Debating on Potential New RefinementsGiorgio Frega, Andrea Palloni, Giuseppe Di Pasquale, et al.
Pageof 39

Showing results (181-190 of 381) with videos related to

Sort By:
Pageof 39
Expert Opinion on Drug Safety|April 13, 2023
An update on safety evaluation of immune-based combinations in patients with advanced renal cell carcinomaMatteo Rosellini, Elisa Tassinari, Andrea Marchetti, et al.
Nature Computational Science|January 13, 2024
Vector-based pedestrian navigation in citiesChristian Bongiorno, Yulun Zhou, Marta Kryven, et al.
Expert Opinion on Investigational Drugs|June 25, 2021
Lenvatinib plus pembrolizumab: the next frontier for the treatment of hepatocellular carcinoma?Alessandro Rizzo, Vincenzo Dadduzio, Angela Dalia Ricci, et al.
Anti-Cancer Drugs|August 13, 2021
Platinum-based adjuvant chemotherapy for upper tract urothelial carcinoma: a change of paradigm? A meta-analysis of aggregate dataAngela Dalia Ricci, Alessandro Rizzo, Veronica Mollica, et al.
Applied Network Science|October 3, 2022
Activity-driven network modeling and control of the spread of two concurrent epidemic strainsDaniel Alberto Burbano Lombana, Lorenzo Zino, Sachit Butail, et al.
Frontiers in Molecular Biosciences|December 19, 2022
The association between albumin levels and survival in patients treated with immune checkpoint inhibitors: A systematic review and meta-analysisDeniz Can Guven, Taha Koray Sahin, Enes Erul, et al.
Critical Reviews in Oncology/Hematology|October 14, 2020
Beyond EGFR, ALK and ROS1: Current evidence and future perspectives on newly targetable oncogenic drivers in lung adenocarcinomaGiuseppe Lamberti, Elisa Andrini, Monia Sisi, et al.
Translational Cancer Research|February 4, 2022
Adjuvant treatment in biliary tract cancerAndrea Palloni, Giorgio Frega, Stefania De Lorenzo, et al.
Journal of Personalized Medicine|August 26, 2022
Molecular Profile and Prognostic Value of <i>BAP1</i> Mutations in Intrahepatic Cholangiocarcinoma: A Genomic Database AnalysisAlessandro Rizzo, Riccardo Carloni, Angela Dalia Ricci, et al.
Frontiers in Pharmacology|November 16, 2020
Challenges in Repurposing Drugs in COVID-19 Pandemic. Debating on Potential New RefinementsGiorgio Frega, Andrea Palloni, Giuseppe Di Pasquale, et al.
Pageof 39